30 November 2010 in The Astrophysical Journal
We report on the observation of the region around supernova remnant G65.1+0.6 with the stand-alone MAGIC-I telescope. This region hosts the two bright GeV gamma-ray sources 1FGL J1954.3+2836 and 1FGL J1958.6+2845. They are identified as GeV pulsars and both have a possible counterpart detected at about 35 TeV by the Milagro observatory. MAGIC collected 25.5 hours of good quality data, and found no significant emission in the range around 1 TeV. We therefore report differential flux upper limits, assuming the emission to be point-like (<0.1 deg) or within a radius of 0.3 deg. In the point-like scenario, the flux limits around 1 TeV are at the level of 3 % and 2 % of the Crab Nebula flux, for the two sources respectively. This implies that the Milagro emission is either extended over a much larger area than our point spread function, or it must be peaked at energies beyond 1 TeV, resulting in a photon index harder than 2.2 in the TeV band.
23 December 2025 in Journal of Pharmaceutical and Biomedical Analysis
The biomarker phosphatidylethanol (PEth) can be determined in whole blood to distinguish between alcohol abstinence and alcohol consumption. Routine analysis is commonly performed using dried blood spots (DBS), as PEth is considered stable for extended time periods in this matrix. However, the coexistence of many DBS devices, coupled with insufficient data regarding their comparability of results, pose a major challenge in forensic and clinical practice. We therefore analysed and compared blood samples using three DBS devices commonly employed for PEth testing (Whatman™ filter paper, Mitra® and Capitainer®B Vanadate). PEth 16:0/18:1 and 16:0/18:2 were extracted from DBS using a water/propan-2-ol mixture and subsequent liquid-liquid-extraction using n-hexane. Analysis was carried out via LC-MS/MS. Ethanol and acetaldehyde concentrations were determined in each blood sample via GC-FID. A total of 100 blood samples were analysed, of which 76 were found to be positive for PEth. These included 24 cases with PEth concentrations < 20 ng/mL, 43 cases with concentrations ≥ 20 ng/mL to < 200 ng/mL and nine cases with concentrations ≥ 200 ng/mL. The Mitra® and Capitainer®B Vanadate systems resulted, on average, in higher PEth concentrations compared to Whatman™ filter paper. The percentage deviations ranged from -8-116 % for PEth 16:0/18:1 and from -14-264 % for PEth 16:0/18:2. Ethanol and acetaldehyde above physiological concentrations (1.42 g/L and 0.727 mg/L, respectively) were observed in one case only. While DBS are a reliable method for PEth analysis, the choice of device can influence results and potentially impact interpretations of alcohol use and abstinence.
15 May 2025 in Analytical and Bioanalytical Chemistry
Phosphatidylethanol (PEth) is a direct alcohol biomarker which is used in a variety of clinical and forensic contexts. Due to its limited stability in whole blood, PEth is routinely analysed using dried blood spots (DBS). There are many different commercially available sampling systems for DBS, but data on their comparability is scarce. The aim of this study was to develop and validate a LC-MS/MS method for the quantification of PEth 16:0/18:1 and PEth 16:0/18:2 for three different DBS sampling systems: Whatman™ filter paper (903 Protein Saver Cards), Mitra® and Capitainer®B Vanadate. The transferability of calibration curves and their applicability across these devices should be assessed. The results showed that DBS of all devices could be prepared and analysed using the same procedure. Validation was successful for the devices. The accuracy of QCs was best if quantified using the matching DBS sampling device calibration curve (bias < 15 %). Higher, but still acceptable, bias values were observed when using a Whatman™ calibration curve to quantify PEth in DBS of the Capitainer®B Vanadate system and vice versa. Mitra® QCs should only be quantified using device-specific calibration curves, as in all other cases, accuracy exceeded the limit of 15 %. We recommend analysing samples using device-specific calibrations at all times, as determined PEth concentrations might be crucial for patients and should not be subjected to any avoidable uncertainty. Graphical Abstract
26 June 2025 in Journal of Forensic Sciences
Determination of alcohol markers in post‐mortem cases can be useful to classify drinking habits and potential alcohol habituation prior to death. Phosphatidylethanol (PEth) is a direct alcohol marker and is already commonly used in a variety of contexts. However, its use in the field of post‐mortem toxicology has been scarcely investigated so far. To evaluate its validity, PEth was determined in routinely collected post‐mortem heart blood and femoral vein blood. The stability of PEth under routine storage conditions (−20°C) for a period of 60 days was examined. Post‐mortem blood was collected during medicolegal autopsies and aliquoted. Parts of the samples were used to create dried blood spots (DBS) directly after collection. Further DBS were created using aliquots stored at −20°C on days 1, 2, 7, 14, 30, and 60. LC–MS/MS was used for quantitative PEth analysis, and initial blood alcohol was determined using GC‐FID. Blood was collected from 50 different post‐mortem cases. The heart blood/femoral blood ratio of PEth concentrations varied from 0.32 to 2.36 (mean = approx. 1.00), indicating a good comparability in total but a strong interindividual variation. In all PEth‐positive samples, the PEth concentrations increased by approximately 20% after 24 hours and 70% after 60 days. Post‐sampling formation of PEth was also found in blood samples without detectable amounts of ethanol. Neither storage at −80°C nor the addition of sodium metavanadate led to satisfactory stability of PEth. Based on our findings, the (sole) use of PEth for post‐mortem toxicology caseworks is not recommended.
27 October 2026 in Drug Testing and Analysis
Nitrous oxide has been used as a recreational drug for a long time, but has again gained importance in the past years. Hence, a growing number of road traffic offences involving nitrous oxide have been reported. Thirty‐nine DUID cases associated with alleged nitrous oxide consumption were investigated. Quantification was performed by a validated HS‐GC/MS method, using an appropriate calibration gas as a reference. Case information, especially driving and psychomotor impairments, was evaluated. Nitrous oxide was detected in 37 cases, with concentrations ranging from 0.22 to 17 mL/L (median: 3.7 mL/L). The time interval between the incident and blood sampling ranged from 38 to 144 min (median: 85 min) among all cases. Concomitant drug, alcohol and/or medication uptake was not present in 22 cases. Those cases were of particular interest for the evaluation of impairments. In addition to traffic accidents, driving impairments such as weaving, fluctuating driving speeds, and driving into oncoming traffic were observed. Besides others, impairments such as confusion, slowed coordination, lack of concentration, and vertigo were observed. Those were much more distinct during the police control and tenuous or even missing at the medical examination in most cases. The data show that effects of nitrous oxide are generally short‐lasting but may nevertheless have an acute impact on driving ability. The detection in blood even more than 2 h after an incident demonstrates that nitrous oxide remains detectable in blood for a quite long period. Hence, the data will support forensic‐toxicological casework.